Received Sep 18, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | — |
full flu-like effects; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (full flu-like effects) in a patient of an unknown age and gender who received mRNA-1273.251 (Spikevax LP.8.1 PFS) for COVID-19 prophylaxis. Previously administered products included for COVID-19 prophylaxis: Spikevax NOS (Patient had all the previous covid vaccines). Past adverse reactions to the above products included No adverse effect with Spikevax NOS. In 2025, the patient received dose of mRNA-1273.251 (Spikevax LP.8.1 PFS) (unknown route) .5 milliliter. In 2025, the patient experienced INFLUENZA LIKE ILLNESS (full flu-like effects). At the time of the report, INFLUENZA LIKE ILLNESS (full flu-like effects) outcome was unknown. No concomitant medications were reported. The condition resulted in 1.5 days of bed rest. It was unknown if the patient experienced any additional symptoms/events. No treatment medication was provided. This case was linked to US-MODERNATX, INC.-MOD-2025-789274 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2025-789274:Master case (Reporter's case)